Novel Approach Towards the Bicyclic Moiety of Miharamycin, Employing Ring Closure Metathesis

Mélanie Etheve-Quelquejeu; Juan Xie; Jean-Marc Valéry

doi:10.1055/s-2004-820055

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2004(6): 1089-1091
DOI: 10.1055/s-2004-820055

LETTER

Novel Approach Towards the Bicyclic Moiety of Miharamycin, Employing Ring Closure Metathesis

Mélanie Etheve-Quelquejeu*, Juan Xie, Jean-Marc Valéry
Synthèse, structure et fonction de molécules Bioactives-CNRS UMR 7613-Equipe ‘Chimie des Glucides’, Université Pierre et Marie Curie, 4 place Jussieu, case 179, 75252 Paris, Cedex 05, France
Fax: +33(1)44275513; e-Mail: quelque@ccr.jussieu.fr;

Further Information

Publication History

Received 8 December 2003
Publication Date:
25 March 2004 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

The ring closing metathesis has been successfully used in the construction of the bicyclic moiety of miharamycin from 2-O-allyl-3-C-methylene sugar.

Key words

carbohydrates - ring closure metathesis - bicyclic - annulation

References

1 Seto H. Koyama M. Ogino H. Tsuruoka T. Inoue S. Otake N. Tetrahedron Lett. 1983, 24: 1805

Crossref Google Scholar
2 Garner P. Yoo JU. Sarabu R. Kennedy VO. Yongs WJ. Tetrahedron 1998, 54: 9303

Crossref Google Scholar
3a Casiraghi G. Colombo L. Rassu G. Spanu P. J. Chem. Soc., Chem. Commun. 1991, 603

Google Scholar
3b Casiraghi G. Colombo L. Rassu G. Spanu P. J. Org. Chem. 1991, 56: 6523

Google Scholar
4a Czernecki S. Horns S. Valéry JM. J. Org. Chem. 1995, 60: 650

Crossref Google Scholar
4b Czernecki S. Franco S. Horns S. Valéry JM. Tetrahedron Lett. 1996, 37: 4003

Crossref Google Scholar
5 Hara K. Fujimoto H. Sato K.-I. Hashimoto H. Yoshimura J. Carbohydr. Res. 1987, 159: 65

Crossref Google Scholar
6 Fairbanks AJ. Sinaӱ P. Synlett 1994, 3: 277

Article in Thieme Connect Google Scholar
7 Rauter AP. Oliveira O. Canda T. Leroi E. Ferreira H. Ferreira MJ. Ascenso JA. J. Carbohydr. Chem. 2002, 21: 257

Crossref Google Scholar
For reviews concerning RCM reactions, see:
8a Grubbs RH. Miller SJ. Fu GC. Acc. Chem. Res. 1995, 28: 446

Crossref PubMed Google Scholar
8b Schuster M. Blechert S. Angew. Chem., Int. Ed. Engl. 1997, 36: 2036

Crossref PubMed Google Scholar
8c Armstrong SK. J. Chem. Soc., Perkin Trans. 1 1997, 371

Crossref PubMed Google Scholar
8d Grubbs RH. Chang S. Tetrahedron 1998, 54: 4413

Crossref PubMed Google Scholar
8e Fürstner A. Angew. Chem. Int. Ed. 2000, 39: 3013

Crossref PubMed Google Scholar
8f Trnka TM. Grubbs RH. Acc. Chem. Res. 2001, 34: 18

Crossref PubMed Google Scholar
For reviews, see:
9a Roy R. Das SK. Chem. Commun. 2000, 519

Crossref Google Scholar
9b Sinou D. Bedjeguelal K. J. Carbohydr. Chem. 2001, 20: 335

Crossref Google Scholar
10a Holt DJ. Barker WD. Jenkins PR. Davies DL. Garratt S. Fawcett J. Russell DR. Ghosh S. Angew. Chem. Int. Ed. 1998, 37: 3298

Crossref Google Scholar
10b Dirat O. Vidal T. Langlois Y. Tetrahedron Lett. 1999, 40: 4801

Crossref Google Scholar
10c Holt DJ. Barker WD. Jenkins PR. Panda J. Ghosh S. J. Org. Chem. 2000, 65: 482

Crossref Google Scholar
11 Carey FA. Frank WC. J. Org. Chem. 1982, 47: 3548

Google Scholar
14 Guerra J. Synlett 2003, 423

Article in Thieme Connect Google Scholar
16 Paquette LA. Schloss JD. Efremov I. Fabris F. Gallo F. Mendez-Andino J. Yang J. Org. Lett. 2000, 2: 1259

Crossref Google Scholar
19 Paquette LA. Hartung RE. France DJ. Org. Lett. 2003, 6: 869

Google Scholar
21 Anelli PL. Biffi C. Montanari F. Quici S. J. Org. Chem. 1987, 52: 2559

Crossref Google Scholar

12

Spectral data for 3: ¹H NMR (250 MHz, CDCl₃): δ = 3.43 (s, 3 H, OCH₃), 3.75 (m, 2 H, H-5, H-6), 3.95 (m, 2 H, H-2, CH₂), 4.28 (m, 2 H, H-6′, CH₂), 4.83 (d, 1 H, H-1, J = 3.8 Hz), 5.27 (m, 2 H, CH₂=), 5.60 (s, 1 H, CH), 5.95 (m, 1 H, CH=), 7.35 (m, 3 H, Ph), 7.53 (m, 2 H, Ph). ¹³C NMR (63 MHz, CDCl₃): δ = 55.7 (OCH₃), 66.0 (C5), 69.8 (C6), 72.0 (CH₂), 77.0 (C2), 79.0 (C4), 100.0 (C1), 101.9 (CH), 105.4 (CH₂=), 118.3 (CH₂=), 126.7, 128.7, 129.5 (Ph), 134.8 (CH=). [α]_D ²⁰ +70 (c 1, CH₂Cl₂). MS (NH₃, DCI): 336 [M + 18]⁺.

13

Spectral data for 7: ¹H NMR (250 MHz, CDCl₃): δ = 3.44 (s, 6 H, OCH₃), 3.73 (m, 4 H, H-5, H-6), 3.95 (m, 4 H, H-2, H-4), 4.26 (m, 4 H, CH₂), 4.29 (m, 2 H, H-6), 4.85 (d, 2 H, H-1, J = 3.8 Hz), 5.26 (dd, 4 H, CH₂=), 5.60 (s, 2 H, CH), 5.88 (m, 2 H, CH=), 7.39 (m, 6 H, Ph), 7.54 (m, 4 H, Ph). ¹³C NMR (63 MHz, CDCl₃): δ = 55.7 (OCH₃), 66.0 (C5), 69.8 (C6), 70.8 (CH₂), 77.3 (C2), 78.9 (C4), 99.9 (C1), 101.8 (CH), 105.5 (CH₂=), 126.6, 128.6, 129.5, 130 (Ph), 134.8 (CH=), 139.5 (C_ipso).; MS (NH₃, DCI): 626 [M + 18]⁺.

15

Spectral data for 8: ¹H NMR (250 MHz, CDCl₃): δ = 2.06 (s, 3 H, OAc) 2.15 (s, 3 H, OAc), 3.40 (s, 3 H, OCH₃), 3.85 (m, 1 H, H-5), 3.98-4.14 (m, 4 H, H-2, H-6, H-7, H-7′), 4.29 (m, 1 H, H-6), 4.81 (d, 1 H, H-1, J = 3.7 Hz), 4.97 (br s, 1 H, H-4), 5.20 (m, 4 H, CH₂=), 5.88 (m, 1 H, CH=). ¹³C NMR (63 MHz, CDCl₃): δ = 21.0. 21.1 (CH₃), 55.7 (OCH₃), 62.9 (C6), 69.6 (C5), 70.0 (C2), 72.0 (C7), 76.8 (C4), 99.1 (C1), 106.5 (CH₂=), 134.5 (CH=), 139.2 (C3), 171.1, 169.8 (CO). Optical rotation: [α]_D ²⁰ +66 (c 1, CH₂Cl₂). MS (NH₃, DCI): 332 [M + 18]⁺.

17

Spectal data for 9: ¹H NMR (250 MHz, CDCl₃): δ = 2.09 (s, 3 H, OAc) 2.14 (s, 3 H, OAc), 3.42 (s, 3 H, OCH₃), 3.81 (m, 1 H, H-5), 4.18 (m, 2 H, H-6), 4.73 (m, 1 H, H-2), 4.83 (m, 3 H, H-1, CH₂), 5.42 (dd, 1 H, H-4, J = 2.2 Hz, J = 9.7 Hz), 5.60 (bs, 1 H, CH=). ¹³C NMR (63 MHz, CDCl₃): δ = 21.0. 21.1 (CH₃), 55.8 (OCH₃), 62.8 (C6), 67.7 (C4), 68.9 (C5), 77.7 (C7), 83.7 (C2), 99.7 (C1), 119.2 (CH=), 133.5 (C3), 171.1, 169.9 (CO). [α]_D ²⁰ +204 (c 1, CH₂Cl₂). MS (NH₃, DCI): 304 [M + 18]⁺.

18

Spectral data for 10: ¹H NMR (250 MHz, CDCl₃): δ = 1.6 (br s, 1 H, OH), 2.09 (s, 3 H, OAc) 2.12 (s, 3 H, OAc), 3.39 (s, 3 H, OCH₃), 3.60 (dd, 1 H, H-7), 3.92 (m, 1 H, H-5), 4.10 (d, 1 H, H-2, J = 5.0 Hz), 4.27 (m, 3 H, H-6, H-7′), 4.48 (br s, 1 H, OH), 4.62 (m, 1 H, H-8), 4.73 (d, 1 H, H-1, J = 5.3 Hz), 4.98 (d, 1 H, H-4, J = 10.5 Hz). ¹³C NMR (63 MHz, CDCl₃): δ = 21.1, 21.1 (CH₃), 56.1 (OCH₃), 62.9 (C6), 64.7 (C5), 72.7 (C8), 74 (C7), 74.3 (C4), 78.1 (C3), 83.6 (C2), 98.8 (C1), 173.2, 171.1 (CO). [α]_D ²⁰ +108 (c 1, CH₂Cl₂).

20

Spectral data for 11: ¹H NMR (250 MHz, CDCl₃): δ = 2.06 (s, 3 H, OAc) 2.11 (s, 3 H, OAc), 3.37 (s, 3 H, OCH₃), 3.82 (m, 1 H, H-5), 3.97-4.12 (m, 3 H, H-6, H-7), 4.36 (d, 1 H, H-2, J = 5.3 Hz), 4.54 (dd, 1 H, H-7′, J = 5.8 Hz, J = 10.0 Hz), 4.89 (d, 1 H, H-1, J = 5.3 Hz), 5.25 (dd, 1 H, H-8, J = 6.0 Hz, J = 1.8 Hz), 5.42 (d, 1 H, H-4, J = 10.5 Hz). ¹³C NMR (63 MHz, CDCl₃): δ = 20.5, 20.2 (CH₃), 55.4 (OCH₃), 61.8 (C6), 64.1 (C5), 67.4 (C4), 75.4 (C7), 79.3 (C2), 80.4 (C8), 98.9 (C1), 153.0 (CO), 168.7, 170.4 (CO). [α]_D ²⁰ +67 (c 1.2, CH₂Cl₂). MS (NH₃, DCI): 364 [M + 18]⁺. IR 1817, 1750 cm^-1 (CO).

22

Spectral data for 12: ¹H NMR (250 MHz, CDCl₃): δ = 2.10 (s, 3 H, OAc) 2.19 (s, 3 H, OAc), 3.40 (s, 3 H, OCH₃), 4.00 (m, 1 H, H-5), 4.18-4.30 (m, 5 H, H-2, H-6, H-6′, H-7, H-7′), 4.88 (d, 1 H, H-1, J = 5.5 Hz), 4.92 (br s, 1 H, H-4). ¹³C NMR (63 MHz, CDCl₃): δ = 21.4 (CH₃), 56.3 (OCH₃), 63.0 (C6), 66.0 (C5), 70.6 (C7), 72.5 (C3), 76.6 (C4), 82.0 (C2), 99.1 (C1), 171.3, 175.0 (CO), 207.7 (CO). [α]_D ²⁰ +17 (c 0.3, CH₂Cl₂). MS (NH₃, DCI): 336 [M + 18]⁺.

23

The crystal struture has been deposited at the Cambridge Crystallographic Center and allocated the deposition number: CCDC 224358.

24

Spectral data for 13: ¹H NMR (250 MHz, CDCl₃): δ = 2.11 (s, 3 H, OAc), 2.53 (s, 1 H, OH), 2.95 (s, 1 H, OH), 3.52 (s, 3 H, OCH₃), 3.82 (m, 2 H, H-4, H-5), 3.89 (d, 1 H, H-7, J = 10.3 Hz), 4.02 (d, 1 H, H-2, J = 5.5 Hz), 4.18 (dd, 1 H, H-8, J = 4.8 Hz, J = 12.2 Hz), 4.36 (m, 3 H, 2 H-6, H-7′), 4.53 (d, 1 H, OH, J = 12.2 Hz), 4.86 (d, 1 H, H-1, J = 5.3 Hz). MS (NH₃, DCI): 296 [M + 18]⁺.